{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:07:14Z","timestamp":1793855234808,"version":"4.6.1"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Antipsychotics are being increasingly prescribed during pregnancy and in the postpartum period. However, knowledge regarding the ability of antipsychotics to enter the fetal, newborn, and infant circulation presents inconsistencies. Evidence for penetration ratios in an array of matrices will contribute to further studies examining the mechanistic pathway from antipsychotic use to adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A systematic literature search of PubMed and EMBASE was performed to identify studies assessing the concentrations of antipsychotics in maternal blood (serum or plasma), amniotic fluid, umbilical cord blood, and\/or breast milk. The penetration ratios were estimated by dividing the antipsychotic concentrations in the target matrix (ie, amniotic fluid, umbilical cord blood or breast milk) by the maternal concentration. Data are provided in means with ranges or SD depending on data availability.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Forty-nine eligible studies were identified. For amniotic fluid, the penetration ratios were estimated for quetiapine, clozapine, and flupentixol, with quetiapine displaying the highest ratio (mean 0.59, range 0.09\u20131.70 versus 0.56, range 0.31\u20130.82 for clozapine and 0.24, range 0.23\u20130.24 for flupentixol). For umbilical cord blood, olanzapine had the highest ratio (mean 0.71 \u00b1 0.42) followed by haloperidol (mean 0.66 \u00b1 0.40) and paliperidone (mean 0.53, range 0.50\u20130.58). In case of breast milk, the highest ratio was observed for amisulpride (mean 14.42, range 11.86\u201319.50) followed by clozapine (mean 3.19, range 2.79\u20134.32) and haloperidol (mean 3.11, range 0.59\u20136.67).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The ability of antipsychotics to enter the fetal, newborn, and infant circulation varies considerably among antipsychotics. Given sampling constraints of other matrices, measuring antipsychotic concentrations in maternal blood may represent the least expensive, most readily available, and reliable estimate of fetal\/infant exposure.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000692","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T07:46:49Z","timestamp":1566028009000},"page":"245-254","source":"Crossref","is-referenced-by-count":39,"title":["Excretion of Antipsychotics Into the Amniotic Fluid, Umbilical Cord Blood, and Breast Milk: A Systematic Critical Review and Combined Analysis"],"prefix":"10.1097","volume":"42","author":[{"given":"Georgios","family":"Schoretsanitis","sequence":"first","affiliation":[{"name":"Department of Psychiatry Research, The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas A.","family":"Westin","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, St Olav University Hospital, Trondheim, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Deligiannidis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Research, The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York;"},{"name":"The Zucker School of Medicine, Hempstead;"},{"name":"The Feinstein Institute for Medical Research, Manhasset, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, St Olav University Hospital, Trondheim, Norway;"},{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Paulzen","sequence":"additional","affiliation":[{"name":"Alexianer Hospital Aachen, Aachen; and"},{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University and JARA\u2014Translational Brain Medicine, Aachen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00737-013-0330-6","article-title":"Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001\u20132007: a population-based study of 585,615 deliveries","volume":"16","author":"Toh","year":"2013","journal-title":"Arch Womens Ment Health."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/appi.ajp.2018.17040393","article-title":"Continuation of atypical antipsychotic medication during early pregnancy and the risk of gestational diabetes","volume":"175","author":"Park","year":"2018","journal-title":"Am J Psychiatry."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"pii: e003062","DOI":"10.1136\/bmjopen-2013-003062","article-title":"Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study","volume":"3","author":"Sadowski","year":"2013","journal-title":"BMJ Open."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/2042098614522682","article-title":"Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects","volume":"5","author":"Galbally","year":"2014","journal-title":"Ther Adv Drug Saf."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1176\/appi.ajp.2015.15040506","article-title":"Reproductive safety of second-generation antipsychotics: current data from the Massachusetts general hospital national pregnancy registry for atypical antipsychotics","volume":"173","author":"Cohen","year":"2016","journal-title":"Am J Psychiatry."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","article-title":"Antipsychotic use in pregnancy and the risk for congenital malformations","volume":"73","author":"Huybrechts","year":"2016","journal-title":"JAMA Psychiatry."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","article-title":"Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study","volume":"33","author":"Habermann","year":"2013","journal-title":"J Clin Psychopharmacol."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"e94788","DOI":"10.1371\/journal.pone.0094788","article-title":"A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies","volume":"9","author":"Kulkarni","year":"2014","journal-title":"PLoS One."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","article-title":"Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes","volume":"164","author":"Newport","year":"2007","journal-title":"Am J Psychiatry."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1055\/s-2000-7974","article-title":"Healthy outcome under olanzapine treatment in a pregnant woman","volume":"33","author":"Kirchheiner","year":"2000","journal-title":"Pharmacopsychiatry."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/clpt.2011.66","article-title":"The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs","volume":"90","author":"Hutson","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1592\/phco.25.3.411.61597","article-title":"The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding","volume":"25","author":"Whitby","year":"2005","journal-title":"Pharmacotherapy."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4088\/JCP.v60n0803","article-title":"Excretion of paroxetine into breast milk","volume":"60","author":"Ohman","year":"1999","journal-title":"J Clin Psychiatry."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s40262-018-0713-y","article-title":"Comprehensive measurements of intrauterine and postnatal exposure to lamotrigine","volume":"58","author":"Paulzen","year":"2019","journal-title":"Clin Pharmacokinet."},{"key":"R15-20230814","first-page":"1","article-title":"Should pregnant women receive lower or higher medication doses?","volume":"138","author":"Westin","year":"2018","journal-title":"Tidsskr Nor Laegeforen."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JCP.0000000000000087","article-title":"Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring","volume":"34","author":"Deligiannidis","year":"2014","journal-title":"J Clin Psychopharmacol."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0895-4356(96)00360-5","article-title":"Is meta-analysis a valid approach to the evaluation of small effects in observational studies?","volume":"50","author":"Shapiro","year":"1997","journal-title":"J Clin Epidemiol."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/17512433.2017.1345623","article-title":"A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone","volume":"10","author":"Schoretsanitis","year":"2017","journal-title":"Expert Rev Clin Pharmacol."},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/17512433.2018.1549489","article-title":"A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting paliperidone","volume":"11","author":"Schoretsanitis","year":"2018","journal-title":"Expert Rev Clin Pharmacol."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/17512433.2018.1478727","article-title":"A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone","volume":"11","author":"Schoretsanitis","year":"2018","journal-title":"Expert Rev Clin Pharmacol."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/cpt.770","article-title":"Treatment with antipsychotics in pregnancy: changes in drug disposition","volume":"103","author":"Westin","year":"2018","journal-title":"Clin Pharmacol Ther."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/JCP.0000000000000171","article-title":"Perinatal use of aripiprazole: plasma levels, placental transfer, and child outcome in 3 new cases","volume":"34","author":"Windhager","year":"2014","journal-title":"J Clin Psychopharmacol."},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/JCP.0b013e31815a57d8","article-title":"Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum","volume":"27","author":"Klier","year":"2007","journal-title":"J Clin Psychopharmacol."},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1176\/ajp.151.6.945","article-title":"Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk","volume":"151","author":"Barnas","year":"1994","journal-title":"Am J Psychiatry."},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0269881105049044","article-title":"Risperidone and breast-feeding","volume":"19","author":"Aichhorn","year":"2005","journal-title":"J Psychopharmacol."},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1017\/S0033291797005965","article-title":"Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants","volume":"28","author":"Yoshida","year":"1998","journal-title":"Psychol Med."},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.schres.2017.09.043","article-title":"Pregnancy exposure to quetiapine\u2014therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomes","volume":"195","author":"Paulzen","year":"2018","journal-title":"Schizophr Res."},{"key":"R30-20230814","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pnpbp.2017.06.030","article-title":"Pregnancy exposure to citalopram - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","volume":"79","author":"Paulzen","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fphar.2018.00264","article-title":"Clozapine use during pregnancy and lactation: a case-series report","volume":"9","author":"Imaz","year":"2018","journal-title":"Front Pharmacol."},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1007\/s00213-014-3647-6","article-title":"Olanzapine treatment during pregnancy and breastfeeding: a chance for women with psychotic illness?","volume":"231","author":"Stiegler","year":"2014","journal-title":"Psychopharmacology (Berl)."},{"key":"R33-20230814","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0269881106074065","article-title":"Placental transfer of quetiapine in relation to P-glycoprotein activity","volume":"21","author":"Rahi","year":"2007","journal-title":"J Psychopharmacol."},{"key":"R34-20230814","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0024-3205(02)01680-6","article-title":"In vitro P-glycoprotein affinity for atypical and conventional antipsychotics","volume":"71","author":"Boulton","year":"2002","journal-title":"Life Sci."},{"key":"R35-20230814","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2004-832687","article-title":"The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry","volume":"37","author":"Baumann","year":"2004","journal-title":"Pharmacopsychiatry."},{"key":"R36-20230814","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1210\/jcem-48-3-478","article-title":"Augmentation of puerperal lactation by oral administration of sulpiride","volume":"48","author":"Aono","year":"1979","journal-title":"J Clin Endocrinol Metab."},{"key":"R37-20230814","first-page":"144","article-title":"Sulpiride isomers and milk secretion in puerperium","volume":"9","author":"Polatti","year":"1982","journal-title":"Clin Exp Obstet Gynecol."},{"key":"R38-20230814","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1208\/s12248-014-9649-9","article-title":"The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family","volume":"16","author":"Dos Santos Pereira","year":"2014","journal-title":"AAPS J."},{"key":"R39-20230814","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/FTD.0b013e3181f88f70","article-title":"Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression","volume":"32","author":"Ilett","year":"2010","journal-title":"Ther Drug Monit."},{"key":"R40-20230814","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/JCP.0000000000000079","article-title":"Transfer of aripiprazole to breast milk: a case report","volume":"34","author":"Nordeng","year":"2014","journal-title":"J Clin Psychopharmacol."},{"key":"R41-20230814","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/bfm.2010.0016","article-title":"Estimation of rac-amisulpride transfer into milk and of infant dose via milk during its use in a lactating woman with bipolar disorder and schizophrenia","volume":"6","author":"Teoh","year":"2011","journal-title":"Breastfeed Med."},{"key":"R42-20230814","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00737-018-0840-3","article-title":"Long-acting olanzapine injection during pregnancy and breastfeeding: a case report","volume":"21","author":"Manouilenko","year":"2018","journal-title":"Arch Womens Ment Health."},{"key":"R43-20230814","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1746-4358-4-7","article-title":"Is increased fat content of hindmilk due to the size or the number of milk fat globules?","volume":"4","author":"Mizuno","year":"2009","journal-title":"Int Breastfeed J."},{"key":"R44-20230814","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.2042-7158.1970.tb08496.x","article-title":"Plasma protein binding of chlorpromazine","volume":"22","author":"Curry","year":"1970","journal-title":"J Pharm Pharmacol."},{"key":"R45-20230814","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/BF02244986","article-title":"Plasma protein binding of risperidone and its distribution in blood","volume":"114","author":"Mannens","year":"1994","journal-title":"Psychopharmacology (Berl)."},{"key":"R46-20230814","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/bfm.2007.9978","article-title":"ABM clinical protocol #18: use of antidepressants in nursing mothers","volume":"3","year":"2008","journal-title":"Breastfeed Med."},{"key":"R47-20230814","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00433814","article-title":"Concentrations of Cis(Z)-flupentixol in maternal serum, amniotic fluid, umbilical cord serum, and milk","volume":"72","author":"Kirk","year":"1980","journal-title":"Psychopharmacology (Berl)."},{"key":"R48-20230814","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2739\/kurumemedj.32.199","article-title":"Haloperidol and biperiden plasma levels in a pregnant atypical psychotic woman and a neonate\u2014a case report","volume":"32","author":"Kuniyoshi","year":"1985","journal-title":"Kurume Med J."},{"key":"R49-20230814","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3109\/00048674.2011.566547","article-title":"Placental transfer of aripiprazole","volume":"45","author":"Nguyen","year":"2011","journal-title":"Aust N Z J Psychiatry."},{"key":"R50-20230814","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/JCP.0b013e318218c400","article-title":"Perinatal use of aripiprazole: a case report","volume":"31","author":"Watanabe","year":"2011","journal-title":"J Clin Psychopharmacol."},{"key":"R51-20230814","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0269881107083849","article-title":"Olanzapine plasma concentration in a newborn","volume":"22","author":"Aichhorn","year":"2008","journal-title":"J Psychopharmacol."},{"key":"R52-20230814","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/JCP.0000000000000714","article-title":"Placental transfer of paliperidone during treatment with a depot formulation","volume":"37","author":"Binns","year":"2017","journal-title":"J Clin Psychopharmacol."},{"key":"R53-20230814","article-title":"Obstetric and neonatal outcomes of clozapine exposure in pregnancy: a consecutive case series","author":"Nguyen","year":"2019","journal-title":"Arch Womens Ment Health."},{"key":"R54-20230814","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1176\/ajp.119.2.178-a","article-title":"Mother's milk and chlorpromazine","volume":"11","author":"Blacker","year":"1962","journal-title":"Am J Psychiatry."},{"key":"R55-20230814","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00179202","article-title":"Zuclopenthixol levels in serum and breast milk","volume":"90","author":"Aaes-Jorgensen","year":"1986","journal-title":"Psychopharmacology (Berl)."},{"key":"R56-20230814","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2125.1978.tb01639.x","article-title":"Chlorpromazine levels in plasma and milk of nursing mothers","volume":"5","author":"Wiles","year":"1978","journal-title":"Br J Clin Pharmacol."},{"key":"R57-20230814","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/bmj.282.6278.1746","article-title":"Haloperidol secreted in breast milk","volume":"282","author":"Whalley","year":"1981","journal-title":"Br Med J (Clin Res Ed)."},{"key":"R58-20230814","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF00556901","article-title":"Presence of chlorprothixene and its metabolites in breast milk","volume":"27","author":"Matheson","year":"1984","journal-title":"Eur J Clin Pharmacol."},{"key":"R59-20230814","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00609257","article-title":"Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast differences in two patients","volume":"35","author":"Matheson","year":"1988","journal-title":"Eur J Clin Pharmacol."},{"key":"R60-20230814","first-page":"1","article-title":"Chlorpromazine excretion by the neonate following chronic in utero exposure","volume":"3","author":"Nielsen","year":"1983","journal-title":"Pediatr Pharmacol (New York)."},{"key":"R61-20230814","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/FTD.0000000000000300","article-title":"A liquid chromatography-tandem mass spectrometry method for quantifying amisulpride in human plasma and breast milk, applied to measuring drug transfer to a fully breast-fed neonate","volume":"38","author":"O'Halloran","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R62-20230814","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/JCP.0b013e3181d27c7d","article-title":"Aripiprazole in pregnancy and lactation: a case report","volume":"30","author":"Lutz","year":"2010","journal-title":"J Clin Psychopharmacol."},{"key":"R63-20230814","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S1461145707007602","article-title":"Aripiprazole in human milk","volume":"10","author":"Schlotterbeck","year":"2007","journal-title":"Int J Neuropsychopharmacol."},{"key":"R64-20230814","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1017\/S1461145709009936","article-title":"Low concentration of ziprasidone in human milk: a case report","volume":"12","author":"Schlotterbeck","year":"2009","journal-title":"Int J Neuropsychopharmacol."},{"key":"R65-20230814","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.jcp.0000106225.36344.58","article-title":"Olanzapine excretion into breast milk: a case report","volume":"24","author":"Ambresin","year":"2004","journal-title":"J Clin Psychopharmacol."},{"key":"R66-20230814","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/JCP.0000000000000291","article-title":"Olanzapine and quetiapine use during breastfeeding: excretion into breast milk and safe breastfeeding strategy","volume":"35","author":"Aydin","year":"2015","journal-title":"J Clin Psychopharmacol."},{"key":"R67-20230814","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1017\/S1461145702003012","article-title":"Olanzapine excretion in human breast milk: estimation of infant exposure","volume":"5","author":"Croke","year":"2002","journal-title":"Int J Neuropsychopharmacol."},{"key":"R68-20230814","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1176\/appi.ajp.160.8.1428","article-title":"Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants","volume":"160","author":"Gardiner","year":"2003","journal-title":"Am J Psychiatry."},{"key":"R69-20230814","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1176\/ajp.147.10.1378","article-title":"Perphenazine in breast milk and serum","volume":"147","author":"Olesen","year":"1990","journal-title":"Am J Psychiatry."},{"key":"R70-20230814","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1176\/ajp.137.7.849","article-title":"Haloperidol excretion in human milk","volume":"137","author":"Stewart","year":"1980","journal-title":"Am J Psychiatry."},{"key":"R71-20230814","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/FTD.0b013e31816850e2","article-title":"Olanzapine treatment during breast feeding: a case report","volume":"30","author":"Lutz","year":"2008","journal-title":"Ther Drug Monit."},{"key":"R72-20230814","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1176\/appi.ajp.161.9.1715-a","article-title":"Excretion of quetiapine in breast milk","volume":"161","author":"Lee","year":"2004","journal-title":"Am J Psychiatry."},{"key":"R73-20230814","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.jcp.0000236656.70544.f3","article-title":"Quetiapine augmentation in lactation: a series of case reports","volume":"26","author":"Misri","year":"2006","journal-title":"J Clin Psychopharmacol."},{"key":"R74-20230814","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004714-200004000-00036","article-title":"Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding","volume":"20","author":"Hill","year":"2000","journal-title":"J Clin Psychopharmacol."},{"key":"R75-20230814","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1345\/aph.1D326","article-title":"Transfer of risperidone and 9-hydroxyrisperidone into human milk","volume":"38","author":"Ilett","year":"2004","journal-title":"Ann Pharmacother."},{"key":"R76-20230814","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1345\/aph.1H555","article-title":"Quetiapine and breast feeding","volume":"41","author":"Rampono","year":"2007","journal-title":"Ann Pharmacother."},{"key":"R77-20230814","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/JCP.0b013e318206c218","article-title":"A case report of risperidone distribution and excretion into human milk: how to give good advice if you have not enough data available","volume":"31","author":"Weggelaar","year":"2011","journal-title":"J Clin Psychopharmacol."},{"key":"R78-20230814","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881108096504","article-title":"Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months","volume":"24","author":"Whitworth","year":"2010","journal-title":"J Psychopharmacol."},{"key":"R79-20230814","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/JCP.0000000000000905","article-title":"Quetiapine excretion into human breast milk","volume":"38","author":"Yazdani-Brojeni","year":"2018","journal-title":"J Clin Psychopharmacol."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:38:34Z","timestamp":1692052714000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000692","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}